157 results on '"Ruvoletto, Mariagrazia"'
Search Results
2. 1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition.
3. SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis
4. Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.
5. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation
6. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma
7. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2
8. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation.
9. Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
10. SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness
11. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study
12. Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
13. Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice
14. The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment
15. SerpinB3 administration protects liver against ischemia-reperfusion injury
16. Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo
17. Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour?
18. SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
19. SERPINB3 modulates TGF-β expression in chronic liver disease
20. Engineered EVs for Oxidative Stress Protection
21. Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma
22. WED-449 - Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
23. SERPINB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis
24. SERPINB3 induces epithelial–mesenchymal transition
25. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma
26. Profiles of HCV Core Protein and Viremia in Chronic Hepatitis C: Possible Protective Role of Core Antigen in Liver Damage
27. Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici
28. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis
29. SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
30. FRI-117-The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity of portal hypertension and complications onset in patients with advanced liver disease
31. MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
32. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer
33. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer
34. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity
35. CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice
36. Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles
37. RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA
38. Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante
39. Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis
40. SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION
41. SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY
42. Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico
43. SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE
44. ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA
45. Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model
46. SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE
47. SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE
48. PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING
49. DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA
50. Does HCV infection have a more favourable outcome in Tanzanian people? Data from the Lugalawa study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.